IRadimed (Germany) Alpha and Beta Analysis

46K Stock   83.50  3.00  3.47%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as IRadimed. It also helps investors analyze the systematic and unsystematic risks associated with investing in IRadimed over a specified time horizon. Remember, high IRadimed's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to IRadimed's market risk premium analysis include:
Beta
0.34
Alpha
0.22
Risk
1.9
Sharpe Ratio
0.15
Expected Return
0.28
Please note that although IRadimed alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, IRadimed did 0.22  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of IRadimed stock's relative risk over its benchmark. IRadimed has a beta of 0.34  . As returns on the market increase, IRadimed's returns are expected to increase less than the market. However, during the bear market, the loss of holding IRadimed is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out IRadimed Analysis, IRadimed Valuation, IRadimed Correlation, IRadimed Hype Analysis, IRadimed Volatility, IRadimed Price History and analyze IRadimed Performance.

IRadimed Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. IRadimed market risk premium is the additional return an investor will receive from holding IRadimed long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IRadimed. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate IRadimed's performance over market.
α0.22   β0.34

IRadimed expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of IRadimed's Buy-and-hold return. Our buy-and-hold chart shows how IRadimed performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

IRadimed Market Price Analysis

Market price analysis indicators help investors to evaluate how IRadimed stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IRadimed shares will generate the highest return on investment. By understating and applying IRadimed stock market price indicators, traders can identify IRadimed position entry and exit signals to maximize returns.

IRadimed Return and Market Media

The median price of IRadimed for the period between Sun, Nov 16, 2025 and Sat, Feb 14, 2026 is 81.0 with a coefficient of variation of 5.68. The daily time series for the period is distributed with a sample standard deviation of 4.56, arithmetic mean of 80.33, and mean deviation of 3.56. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
How IRADIMED CORPORATION stock reacts to job market data - 2025 Bull vs Bear High Accuracy Investment Signals - B NI V
11/27/2025
2
IRADIMED Assessing Valuation After Strong MultiYear Share Price Gains - simplywall.st
12/16/2025
3
iRadimed Hits New 12-Month High - Still a Buy - MarketBeat
12/29/2025
4
Momentum Shift Can IRADIMED CORPORATION stock beat market expectations this quarter - Watch List AI Driven Stock Reports - moha.gov.vn
01/02/2026
5
Will IRADIMED CORPORATION stock maintain momentum in 2025 - Market Volume Summary Weekly Watchlist of Top Performers - ulpravda.ru
01/08/2026
6
IRadimed Corporation Accelerating with Solid Capital Return - Yahoo Finance Canada
01/19/2026
7
Insider Transaction Roger E Susi Sells 503K Worth Of iRadimed Shares - Benzinga
01/28/2026
8
Uncovering Potential iRadimeds Earnings Preview - Benzinga
02/09/2026
9
Why Iradimed Stock Soared Today - AOL.com
02/13/2026

About IRadimed Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including IRadimed or other stocks. Alpha measures the amount that position in IRadimed has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IRadimed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IRadimed's short interest history, or implied volatility extrapolated from IRadimed options trading.

Build Portfolio with IRadimed

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for IRadimed Stock Analysis

When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.